Indivior (INDV)

Sector: Pharma and Biotech     Index: FTSE 250
-1.31%
-4.90p
367.90p
09:50 28/07/17
367.90p
09:50 28/07/17
DAILY VARIATION
-1.31%
-4.90p
VOLUME
566,982
REAL TIME BATS
368.20p
09:54 28/07/17
-1.21%
-4.50p
DATA
52 Week High
372.80p
52 Week Low
272.50p
Shares Issued
720.99m
Market Cap
£2,652.52m
RiskGrade
250
Beta
0.64
MENU

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 14.1% 30.6%
ROCE 75.6%
Latest F'cast
P/E 13.9 13.0
PEG 4.7 -1.5
Pr/Revenue 3.3 2.7
Pr/Book -11.9
Latest F'cast
Revenue 4.3% 0.0%
PBT -65.6% n/a
EPS 2.9% 0.0%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2014-12-31 1,115.00 561.00 58.00¢ 4.0 0.0 n/a n/a 0.0%
2015-12-31 1,014.00 285.00 34.00¢ 8.1 -0.2 -41% 12.70¢ 4.6%
2016-12-31 1,058.00 98.00 35.00¢ 10.4 3.5 3% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 828.52 253.68 24.70p 13.0 -1.6 -8% 0.00p 0.0%
2018-12-31 857.10 260.79 26.00p 12.2 2.3 5% 0.00p 0.0%

Regulatory News

slide to see more
Half Year Financial Results 27-Jul-17 07:05
Notice of Results 13-Jul-17 14:00
RBP-6000 Investor Event Reminder 29-Jun-17 11:01